To compare best-corrected visual acuity (BCVA) and central macular thickness (CMT) after 532-nm subthreshold laser grid photocoagulation and threshold laser grid photocoagulation for the treatment of ...

The VIBRANT study was a 24-week, double-masked, active-controlled, randomized, phase 3 trial comparing intravitreal aflibercept injection to macular grid laser photocoagulation for the treatment of ...

To compare the efficacy of subthreshold diode laser photocoagulation with conventional threshold diode laser in clinically significant macular oedema (CSME) in diabetics. Prospective randomised ...

Please provide your email address to receive an email when new articles are posted on . The Diabetic Retinopathy Clinical Research Network is making real-world impacts on the way physicians treat and ...

Diabetic eye disease is a leading cause of vision loss in individuals aged 20 to 74,(3) and diabetic macular edema (DME), left untreated, is the leading cause of blindness in diabetic patients. The ...

Since the mid-1980s, center-involved diabetic macular edema (CI-DME) was primarily treated by laser photocoagulation. This began to change approximately a decade ago, when multiple trials demonstrated ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio ORLANDO, Fla. — A study here showed ...